Anzeige
Mehr »
Login
Samstag, 04.12.2021 Börsentäglich über 12.000 News von 683 internationalen Medien
Unfassbar! New Yorker Investmentbank der ersten Reihe ruft 25-USD-Kursziel aus! +735%
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2PT5G ISIN: CA71716W1059 Ticker-Symbol: G111 
Frankfurt
03.12.21
19:56 Uhr
0,023 Euro
+0,004
+17,95 %
Branche
Pharma
Aktienmarkt
Sonstige
1-Jahres-Chart
PHARMADRUG INC Chart 1 Jahr
5-Tage-Chart
PHARMADRUG INC 5-Tage-Chart

Aktuelle News zur PHARMADRUG Aktie

  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
PHARMADRUG Aktie jetzt für 0€ handeln
DiPharmadrug Inc: Pharmadrug completes pre-IND meeting for PD-001-
DiPharmadrug Inc.: Pharmadrug Announces Successful Completion of Pre-IND Meeting with FDA Regarding Proposed Development of Its Cepharanthine for Treatment of Mild to Moderate COVID-19 Infection173Established alignment with FDA on the path forward for the development of PD-001, a patented enteric-coated formulation of cepharanthine, towards clinical studies for mild-moderate COVID-19 infectionMeeting...
► Artikel lesen
19.11.XFRA NEW INSTRUMENTS AVAILABLE ON XETRA - 19.11.2021335The following instruments on XETRA do have their first trading 19.11.2021 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag am 19.11.2021 Aktien 1 CAC2428P1355 Tesla Inc. CDR 2...
► Artikel lesen
18.11.Pharmadrug Inc: Pharmadrug releases cepharanthine study results-
18.11.Pharmadrug Inc.: PharmaDrug Provides Research Results and Initiates IND-Enabling Studies for Cepharanthine in the Treatment of Multiple Cancers174Results of the 4 cancer types where cepharanthine provides exceptional potency and/or synergistic inhibitory effects when combined with standard of care (SoC) chemotherapy provides support for next...
► Artikel lesen
05.11.Pharmadrug Inc: Pharmadrug to begin DMT vitro characterization-
05.11.Pharmadrug Inc.: PharmaDrug Advances Psychedelics Program with Analogue DMT Formulations to Treat Eye Diseases182PharmaDrug narrows list of candidate tryptamine molecules for the treatment of primary open angle glaucoma (PAOG)Terasaki Institute receives PharmaDrug's two candidate DMT analogue molecules Terasaki...
► Artikel lesen
01.11.Pharmadrug Inc: Pharmadrug unit signs supply deal for dronabinol-
01.11.Pharmadrug Inc.: PharmaDrug Expands Product Offering to Prepare for Potential Adult Use Market in Germany235Toronto, Ontario--(Newsfile Corp. - November 1, 2021) - PharmaDrug Inc. (CSE: PHRX) (OTCQB: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the research, development...
► Artikel lesen
20.10.Pharmadrug Inc: Pharmadrug begins trading on OTCQB Venture Market-
20.10.Pharmadrug Inc.: PharmaDrug Commences Trading on the OTCQB Market in the United States183Toronto, Ontario--(Newsfile Corp. - October 20, 2021) - PharmaDrug Inc. (CSE: PHRX) (OTCQB: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the research, development...
► Artikel lesen
15.10.Pharmadrug Inc: Pharmadrug releases interim results from cancer study-
15.10.Pharmadrug Inc.: PharmaDrug Announces Positive Research Results for Cepharanthine in the Treatment of Multiple Cancers When Used Alone and in Combination with Chemotherapy193Cepharanthine reproducibly demonstrates potential as a monotherapy in treating multiple cancers with unsatisfactory treatment optionsIdentified 4 cancer types where cepharanthine provides additive...
► Artikel lesen
28.09.Pharmadrug Inc: Pharmadrug granted pre-IND meeting with FDA1
28.09.Pharmadrug Inc.: PharmaDrug Announces pre-IND Meeting Request Granted by FDA for Oral Antiviral Drug Cepharanthine for the Treatment of COVID-19 Infection214Toronto, Ontario--(Newsfile Corp. - September 28, 2021) - PharmaDrug Inc. (CSE: PHRX) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the development...
► Artikel lesen
23.09.Pharmadrug Inc: Pharmadrug to release functional mushroom products1
23.09.Pharmadrug Inc.: PharmaDrug's Super Smart Launches Slim MycoWeRx Brand of Functional Mushrooms288Toronto, Ontario--(Newsfile Corp. - September 23, 2021) - PharmaDrug Inc. (CSE: PHRX) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company") a specialty pharmaceutical company focused on the research, development...
► Artikel lesen
30.08.Psyched: Cybin Gets $9 Price Target, FSD Pharma Acquires Lucid, New Trials From Psilera, Awakn, PharmaDrug And Braxia, California Bill Put On Hold53
30.08.Pharmadrug Inc.: Biotech Veteran David Kideckel Joins the Board of PharmaDrug233Toronto, Ontario--(Newsfile Corp. - August 30, 2021) - PharmaDrug Inc. (CSE: PHRX) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the research, development...
► Artikel lesen
26.08.PharmaDrug Strikes Deal With Johns Hopkins University For A Clinical Trial Into Psychedelic DMT1
Seite:  Weiter >>
60 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1